Safety of lornoxicam in the treatment of postoperative pain: a post-marketing study of analgesic regimens containing lornoxicam compared with standard analgesic treatment in 3752 day-case surgery patients.

Background: Post-marketing surveillance studies can provide supplemental data on the safety of medications in the general population.

Objective: This study aimed to evaluate the safety of analgesic regimens including the NSAID lornoxicam in the short-term treatment of postoperative pain in a clinically relevant population.

Study Design: Randomized, open-label, multicentre, multinational, observational cohort study of 4 days' duration.